Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

Doxorubicin (DOX) is a prevalent chemotherapeutic drug for treating several malignancies. However, the mechanisms of DOX induced cardiac toxicity is not fully understood. Previous studies have demonstrated that autophagy activation is essential in DOX-induced cardiac toxicity. Nevertheless, studies...

Full description

Saved in:
Bibliographic Details
Main Authors: Ai-Li Xu, Zheng Shen, Shi-Hao Wang, Hai-Yun Luan, Yong Xu, Ze-Chun Kang, Zi-Qi Liao, Jie Liu, Xiao-Lei Duan, Wei-Hua Bian, Hui Sun, Xin Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1496380/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584360689139712
author Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian
Hui Sun
Xin Xie
author_facet Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian
Hui Sun
Xin Xie
author_sort Ai-Li Xu
collection DOAJ
description Doxorubicin (DOX) is a prevalent chemotherapeutic drug for treating several malignancies. However, the mechanisms of DOX induced cardiac toxicity is not fully understood. Previous studies have demonstrated that autophagy activation is essential in DOX-induced cardiac toxicity. Nevertheless, studies on the role of autophagy protein 5 (ATG5) in DOX-induced cardiac toxicity remain limited. Therefore, this study aimed to investigate the role of ATG5 in DOX-induced cardiac toxicity. Mice were intravenously administered DOX (5 mg/kg) for 4 weeks to establish a cardiac toxicity model. Heart function was determined using echocardiography, and cardiac tissue was assessed for protein expression, mRNA levels, fibrosis, and immunofluorescent staining. DOX treatment upregulated autophagy-related gene expression but inhibited autophagic flux in vitro and in vivo. DOX–treated mice exhibited decreased heart function and cardiomyocyte size and increased cardiac fibrosis, oxidative stress, and apoptosis. These effects of DOX were partially alleviated by rAAV9 expressing shRNA-ATG5 and deteriorated by rAAV9-ATG5. We demonstrated that genetic ATG5 knockdown or autophagy inhibition by chemical inhibitors increased GATA4 protein expression, which was reduced by ATG5 overexpression or autophagy activator in vitro and in vivo, suggesting that ATG5-mediated autophagy promoted GATA4 degradation. Moreover, enforced GATA4 re-expression significantly counteracted the toxic effects of ATG5 on DOX-treated hearts. In conclusion, our study demonstrated that manipulating ATG5 expression to regulate GATA4 degradation in the heart may be a promising approach for DOX-induced cardiac toxicity.
format Article
id doaj-art-03f8a356552a4387bf3fe7da1358685d
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-03f8a356552a4387bf3fe7da1358685d2025-01-27T14:11:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14963801496380Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradationAi-Li Xu0Zheng Shen1Shi-Hao Wang2Hai-Yun Luan3Yong Xu4Ze-Chun Kang5Zi-Qi Liao6Jie Liu7Xiao-Lei Duan8Wei-Hua Bian9Hui Sun10Xin Xie11Department of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDepartment of Cardiology, The Binzhou Affiliated Hospital, Binzhou Medical University, Binzhou, ChinaDoxorubicin (DOX) is a prevalent chemotherapeutic drug for treating several malignancies. However, the mechanisms of DOX induced cardiac toxicity is not fully understood. Previous studies have demonstrated that autophagy activation is essential in DOX-induced cardiac toxicity. Nevertheless, studies on the role of autophagy protein 5 (ATG5) in DOX-induced cardiac toxicity remain limited. Therefore, this study aimed to investigate the role of ATG5 in DOX-induced cardiac toxicity. Mice were intravenously administered DOX (5 mg/kg) for 4 weeks to establish a cardiac toxicity model. Heart function was determined using echocardiography, and cardiac tissue was assessed for protein expression, mRNA levels, fibrosis, and immunofluorescent staining. DOX treatment upregulated autophagy-related gene expression but inhibited autophagic flux in vitro and in vivo. DOX–treated mice exhibited decreased heart function and cardiomyocyte size and increased cardiac fibrosis, oxidative stress, and apoptosis. These effects of DOX were partially alleviated by rAAV9 expressing shRNA-ATG5 and deteriorated by rAAV9-ATG5. We demonstrated that genetic ATG5 knockdown or autophagy inhibition by chemical inhibitors increased GATA4 protein expression, which was reduced by ATG5 overexpression or autophagy activator in vitro and in vivo, suggesting that ATG5-mediated autophagy promoted GATA4 degradation. Moreover, enforced GATA4 re-expression significantly counteracted the toxic effects of ATG5 on DOX-treated hearts. In conclusion, our study demonstrated that manipulating ATG5 expression to regulate GATA4 degradation in the heart may be a promising approach for DOX-induced cardiac toxicity.https://www.frontiersin.org/articles/10.3389/fphar.2024.1496380/fullAtg5autophagycardiac toxicitydoxorubicinoxidative stress
spellingShingle Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian
Hui Sun
Xin Xie
Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
Frontiers in Pharmacology
Atg5
autophagy
cardiac toxicity
doxorubicin
oxidative stress
title Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
title_full Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
title_fullStr Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
title_full_unstemmed Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
title_short Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
title_sort knockdown atg5 gene by raav9 alleviates doxorubicin induced cardiac toxicity by inhibiting gata4 autophagic degradation
topic Atg5
autophagy
cardiac toxicity
doxorubicin
oxidative stress
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1496380/full
work_keys_str_mv AT ailixu knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT zhengshen knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT shihaowang knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT haiyunluan knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT yongxu knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT zechunkang knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT ziqiliao knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT jieliu knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT xiaoleiduan knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT weihuabian knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT huisun knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation
AT xinxie knockdownatg5genebyraav9alleviatesdoxorubicininducedcardiactoxicitybyinhibitinggata4autophagicdegradation